Bradykinin facilitates the migration and invasion of BC cells (MDA-MB-231, MCF-7, T47D); these effects were blocked using kinin B1 and B2 receptor antagonists (Des-[Arg9]-Leu8-bradykinin, HOE-140) [38]. Here, KNG1 is linked to breast cancer.